TY - JOUR
AU - Naspitz, C.K.
AB -  REFERENCES 1. Warner JO, Naspitz CK, Cropp GJA. Third International Pediatric Consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1–17. 2. Konig P. Clinical implications of bronchial lability in relation to ¨ asthma. Ph.D. thesis, University of London, 1974. 3. Eigen H, Reid JJ, Dahl R. Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma. J Allergy Clin Immunol 1987;80:612– 621. 4. Cordier R. Sodium cromoglycate delivered by pressurised aerosol in the treatment of adult asthma. Clin Trials J 1984;21:483–491. 5. Rubin AE, Alroy G, Spitzer S. The treatment of asthma in adults using sodium cromoglycate pressurized aerosol: a double-blind controlled trial. Curr Med Res Opin 1983;8:553–558. 6. Selcow JE, Mendelson LM, Rosen JP. Clinical benefits of cromolyn sodium aerosol (MDI) in the treatment of asthma in children. Ann Allergy 1989;62:195–199. 7. Geller-Bernstein C, Levin S. Sodium cromoglycate pressurised aerosol in childhood asthma. Curr Ther Res 1983;34:345–349. 8. Konig P, Shaffer J. The effect of drug therapy on long-term out¨ come of childhood asthma: a possible preview of the international guidelines. J Allergy Clin Immunol 1996;98:1103–1111. 9. Lozewicz S, Robertson CF, Costello JF, Price JF. Delivery of sodium 
TI - Reply by the authors: Third International Pediatric Consensus statement on management of childhood asthma
JF - Pediatric Pulmonology
DO - 10.1002/(SICI)1099-0496(199907)28:1<73::AID-PPUL13>3.0.CO;2-4
DA - 1999-01-01
UR - https://www.deepdyve.com/lp/wiley/reply-by-the-authors-third-international-pediatric-consensus-statement-LyXgton3Iy
SP - 73
EP - 73
VL - 28
IS - 1
DP - DeepDyve
ER -